1180570

Sage Therapeutics, Inc. — FEI 3009322768

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 21, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)